Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer’s-related psychosis during the ...

As the J.P. Morgan Healthcare Conference enters its second day, we're tracking presentations from GSK, Novartis, Sanofi, Eli ...

After selling its PI3Kα program to Eli Lilly, Scorpion will spinout out a different entity, which will be owned by the ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) are two of the most valuable healthcare stocks in the world, largely due ...

Eli Lilly and Company has invested more than $20 billion in its manufacturing capabilities since 2020 to help meet high ...

Alzheimer’s drugs could unlock a $13 billion market by 2030, with Biogen, Eli Lilly, Novo Nordisk, Roche, and UCB leading the ...

Eli Lilly & Co. (NYSE: LLY) is a major global pharmaceutical company in the medical sector. The company made headlines with ...

Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE ... One study suggests that it may even help reduce the risk of developing Alzheimer's. Study shows that belly fat is linked to an increase risk ...

Weight loss drugs such as Zepbound (Eli Lilly) and Wegovy (Novo Nordisk ... such as helping to prevent Alzheimer's, there may be an increase in healthcare coverage for these treatments, making ...

INmune Bio's XPro targets neuroinflammation, showing promising biomarker results in Alzheimer's, with a potential to ...

Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE ... One study suggests that it may even help reduce the risk of developing Alzheimer's. Start Your Mornings Smarter! Wake up with Breakfast news ...